Please check the information that you may find useful for participating in the 13th EPITA Symposium in Innsbruck-Igls. Click on the links to skip to specific content. Scientific Information Presentation guidelines | Registration | Programme | Abstract Book | Posters presenters | Awards | Accreditation | Certificate of Attendance On-site Information Contacts | Food | Networking | Photography and video capture | Social Media | Wi-Fi | Safety | Venue
EPITA – The European Pancreas and Islet Transplant Association- would like to announce a call for nominations for two new Board members. All ESOT/EPITA affiliates are welcome to send nominations for these positions. You may nominate yourself or a colleague. The new EPITA Board Members will hold office for 4 years (2024-2028). In addition, considering
We are pleased to inform you that your application for EACCME® accreditation of 13th EPITA Symposium, Innsbruck-Igls, Austria 28/01/2024 – 30/01/2024 has been granted 11.5 European CME credits (ECMEC®s) by the European Accreditation Council for Continuing Medical Education (EACCME®).
The abstract submission platform will remain open until 23 November 2023 at 23:59 CET.
“What has been achieved in tissue engineering and regenerative medicine?” Tissue engineering and organ regeneration expert, Ekaterine Berishvili, discusses the progress, opportunities and challenges of regeneration and repair in organ transplantation.
EPITA, the scientific community dedicated to islet and pancreas transplantation, is more vibrant and productive than ever!
While preparations for the 12th EPITA Symposium & 41st AIDPIT Workshop are underway, we would like to say a BIG thank you to all our sponsors for their support. THANK YOU. #ESOT_EPITA
Update on our 12th EPITA Symposium & 41st AIDPIT Workshop! You can now find the final programme including Oral Presentations here. #ESOT_EPITA
This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
EPITA encourages applications from either diabetes physicians or nephrologists with an interest in Beta Cell Replacement Therapy or transplant surgeons.